Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases

Human Molecular Genetics

Volumn 12, Issue 17, 2003, Pages 2209-2219

  Paz, Maria F ^a   Wei, Susan ^b   Cigudosa, Juan C ^a   Rodriquez Perales, Sandra ^a   Peinado, Miguel A ^c   Huang, Tim Hui Ming ^b   Esteller, Manel ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b University of Missouri   (United States)

^c Research Institute of Oncology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CALCIUM CHANNEL; CONTIG; DNA METHYLTRANSFERASE; HOMEODOMAIN PROTEIN; THROMBOXANE A2 RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DNA HYBRIDIZATION; DNA METHYLATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE DISRUPTION; GENE LOCUS; GENE SILENCING; GENETIC SCREENING; HOMEOBOX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CADHERINS; CALCIUM CHANNELS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; COLONY-FORMING UNITS ASSAY; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENE TARGETING; GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; PROMOTER REGIONS (GENETICS); RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0041779528     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg226     Document Type: Article

References (36)

1. Fearon, E. (1998) Tumor suppressor genes. In Vogelstein, B. and Kinzler, K.W. (eds), The Genetic Basis of Human Cancer. McGraw-Hill Health Professions Division, New York, pp. 229-240.
2. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
3. Esteller, M. (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21, 5427-5440.
4. Bestor, T.H. (2000) The DNA methyltransferases of mammals. Hum. Mol. Genet., 9, 2395-2402.
5. Robertson, K.D. (2001) DNA methylation, methyltransferases, and cancer. Oncogene, 20, 3139-3155.
6. Chan, T.A., Hermeking, H., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1999) 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage. Nature, 401, 616-620.
7. Rhee, I., Jair, K.W., Yen, R.W., Lengauer, C., Herman, J.G., Kinzler, K.W., Vogelstein, B., Baylin, S.B. and Schuebel, K.E. (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature, 404, 1003-1007.
8. Rhee, I., Bachman, K.E., Park, B.H., Jair, K.W., Yen, R.W., Schuebel, K.E., Cui, H., Feinberg, A.P., Lengauer, C., Kinzler, K.W. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556.
9. Robert, M.F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I.C., Barsalou, A. and MacLeod, A.R. (2003) DNMT1 is required to mantain CpG methylation and aberrant gene silencing in human cancer cells. Nat. Genet., 33, 61-65.
10. Esteller, M., Corn, P.G., Baylin, S.B., and Herman, J.G. (2001) A gene hypermethylation profile of human cancer. Cancer Res., 61, 3225-3229.
11. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C. et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24, 132-138.
12. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G. and Baylin, S.B. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 31, 141-149.
13. Yamashita, K., Upadhyay, S., Osada, M., Hoque, M.O., Xiao, Y., Mori, M., Sato, F., Meltzer, S.J. and Sidransky, D. (2002) Pharmacological unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell, 2, 485-495.
14. Huang, T.H.-M., Perry, M.R. and Laux, D.E. (1999) Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet., 8, 459-470.
15. Yan, P.S, Chen, C.M., Shi, H., Rahmatpanah, F., Wei, S.H., Caldwell, C.W. and Huang, T.H. (2001) Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res., 61, 8375-8380.
16. Frigola, J., Ribas, M., Risques, R.A. and Peinado, M.A. (2002) Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res., 30, E28.
17. Gonzalgo, M.L., Liang, G., Spruck, C.H., III, Zingg, J.M., Rideout, W.M., III and Jones, P.A. (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res., 57, 594-599.
18. Toyota, M., Ho, C., Ahuja, N., Jair, K.W., Li, Q., Ohe-Toyota, M., Baylin, S.B. and Issa, J.P. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59, 2307-2312.
19. Walsh, C.P., Chaillet, J.R. and Bestor, T.H. (1998) Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet., 20, 116-117.
20. Mahoney, P.A, Weber, U., Onofrechuk, P., Biessmann, H., Bryant, P.J. and Goodman, C.S. (1991) The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell, 67, 853-868.
21. Abate-Shen, C. (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat. Rev. Cancer., 2, 777-785.
22. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M.I., Gazdar, A.F. and Minna, J.D. (2001) Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl Acad. Sci. USA, 98, 13954-13959.
23. Yoshikawa, H., Matsubara, K., Qian, G.S., Jackson, P., Groopman, J.D., Manning, J.E., Harris, C.C. and Herman, J.G. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet., 28, 29-35.
24. Cigudosa, J.C., Rao, P.H., Calasanz, M.J., Odero, M.D., Michaeli, J., Jhanwar, S.C. and Chaganti, R.S. (1998) Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood, 91, 3007-3010.
25. Bachman, K.E., Park, B.H., Rhee, I., Rajagopalan, H., Herman, J.G., Baylin, S.B., Kinzler, K.W. and Vogelstein, B. (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell, 3, 89-95.
26. Zhu, W.G., Dai, Z., Ding, H., Srinivasan, K., Hall, J., Duan, W., Villalona-Calero, M.A., Plass, C. and Otterson, G.A. (2001) Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene, 20, 7787-7796.
27. Okano, M. and Li, E. (2002) Genetic analyses of DNA methyltransferase genes in mouse model system. J Nutr., 132, 2462-2465.
28. Antequera, F., Boyes, J. and Bird, A. (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62, 503-514.
29. Smiraglia, D.J., Rush, L.J., Fruhwald, M.C., Dai, Z., Held, W.A., Costello, J.F., Lang, J.C., Eng, C., Li, B., Wright, F.A. et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum. Mol. Genet., 10, 1413-1419.
30. Paz, M.F., Fraga, M.F., Avila, S., Guo, M., Pollan, M., Herman, J.G. and Esteller, M. (2003) A systematic profile of DNA methylation in human cancer cell lines. Cancer Res., 63, 1114-1121.
31. Paredes-Zaglul, A., Kang, J.J., Essig, Y.P., Mao, W., Irby, R., Wloch, M. and Yeatman, T.J. (1998) Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin. Cancer Res., 4, 879-886.
32. Simoneau, M., LaRue, H., Aboulkassim, T.O., Meyer, F., Moore, L. and Fradet, Y. (2000) Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene, 19, 6317-6323.
33. Trojan, J., Brieger, A., Raedle, J., Esteller, M. and Zeuzem, S. (2000) 5′-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut, 47, 272-276.
34. Girard, L., Zochbauer-Muller, S., Virmani, A.K., Gazdar, A.F. and Minna, J.D. (2000) Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res., 60, 4894-4906.
35. Cross, S.H., Charlton, J.A., Nan X. and Bird, A.P. (1994) Purification of CpG islands using a methylated DNA binding column. Nat. Genet., 6, 236-244.
36. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. and Baylin, S.B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.